Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Pro-apoptotic Par-4 and dopamine D2 receptor in temporal cortex in schizophrenia, bipolar disorder and major depression.

Glantz LA, Gilmore JH, Overstreet DH, Salimi K, Lieberman JA, Jarskog LF.

Schizophr Res. 2010 May;118(1-3):292-9. doi: 10.1016/j.schres.2009.12.027. Epub 2010 Jan 13.

2.

Par-4 links dopamine signaling and depression.

Park SK, Nguyen MD, Fischer A, Luke MP, Affar el B, Dieffenbach PB, Tseng HC, Shi Y, Tsai LH.

Cell. 2005 Jul 29;122(2):275-87.

3.

Vesicular glutamate transporter mRNA expression in the medial temporal lobe in major depressive disorder, bipolar disorder, and schizophrenia.

Uezato A, Meador-Woodruff JH, McCullumsmith RE.

Bipolar Disord. 2009 Nov;11(7):711-25. doi: 10.1111/j.1399-5618.2009.00752.x.

PMID:
19839996
4.

Possible involvement of post-dopamine D2 receptor signalling components in the pathophysiology of schizophrenia.

Amar S, Shaltiel G, Mann L, Shamir A, Dean B, Scarr E, Bersudsky Y, Belmaker RH, Agam G.

Int J Neuropsychopharmacol. 2008 Mar;11(2):197-205. Epub 2007 Aug 6.

PMID:
17681085
5.

The neuronal death protein par-4 mediates dopaminergic synaptic plasticity.

Mattson MP, Gleichmann M.

Mol Interv. 2005 Oct;5(5):278-81. Review.

PMID:
16249523
6.

Increased temporal cortex CREB concentrations and antidepressant treatment in major depression.

Dowlatshahi D, MacQueen GM, Wang JF, Young LT.

Lancet. 1998 Nov 28;352(9142):1754-5. No abstract available.

PMID:
9848357
7.

Hippocampal α7 nicotinic acetylcholine receptor levels in patients with schizophrenia, bipolar disorder, or major depressive disorder.

Thomsen MS, Weyn A, Mikkelsen JD.

Bipolar Disord. 2011 Nov-Dec;13(7-8):701-7. doi: 10.1111/j.1399-5618.2011.00961.x.

PMID:
22085484
8.

Cortical bcl-2 protein expression and apoptotic regulation in schizophrenia.

Jarskog LF, Gilmore JH, Selinger ES, Lieberman JA.

Biol Psychiatry. 2000 Oct 1;48(7):641-50.

PMID:
11032975
9.

Abnormalities in the fatty acid composition of the postmortem entorhinal cortex of patients with schizophrenia, bipolar disorder, and major depressive disorder.

Hamazaki K, Hamazaki T, Inadera H.

Psychiatry Res. 2013 Nov 30;210(1):346-50. doi: 10.1016/j.psychres.2013.05.006. Epub 2013 May 31.

PMID:
23731984
10.

Immunodensity and mRNA expression of A2A adenosine, D2 dopamine, and CB1 cannabinoid receptors in postmortem frontal cortex of subjects with schizophrenia: effect of antipsychotic treatment.

Urigüen L, García-Fuster MJ, Callado LF, Morentin B, La Harpe R, Casadó V, Lluis C, Franco R, García-Sevilla JA, Meana JJ.

Psychopharmacology (Berl). 2009 Oct;206(2):313-24. doi: 10.1007/s00213-009-1608-2. Epub 2009 Aug 4.

PMID:
19652957
11.

Abnormal fatty acid pattern in the superior temporal gyrus distinguishes bipolar disorder from major depression and schizophrenia and resembles multiple sclerosis.

McNamara RK, Rider T, Jandacek R, Tso P.

Psychiatry Res. 2014 Mar 30;215(3):560-7. doi: 10.1016/j.psychres.2013.12.022. Epub 2014 Jan 2.

12.

Disruption of the dopamine transporter-dopamine D2 receptor interaction in schizophrenia.

Lee FJ, Pei L, Liu F.

Synapse. 2009 Aug;63(8):710-2. doi: 10.1002/syn.20648. No abstract available.

PMID:
19391151
13.

Apoptotic proteins in the temporal cortex in schizophrenia: high Bax/Bcl-2 ratio without caspase-3 activation.

Jarskog LF, Selinger ES, Lieberman JA, Gilmore JH.

Am J Psychiatry. 2004 Jan;161(1):109-15.

PMID:
14702258
14.

Abnormal glutamate receptor expression in the medial temporal lobe in schizophrenia and mood disorders.

Beneyto M, Kristiansen LV, Oni-Orisan A, McCullumsmith RE, Meador-Woodruff JH.

Neuropsychopharmacology. 2007 Sep;32(9):1888-902. Epub 2007 Feb 14.

15.

Altered levels of extracellular signal-regulated kinase signaling proteins in postmortem frontal cortex of individuals with mood disorders and schizophrenia.

Yuan P, Zhou R, Wang Y, Li X, Li J, Chen G, Guitart X, Manji HK.

J Affect Disord. 2010 Jul;124(1-2):164-9. doi: 10.1016/j.jad.2009.10.017. Epub 2009 Nov 13.

16.

Glial fibrillary acidic protein is reduced in cerebellum of subjects with major depression, but not schizophrenia.

Fatemi SH, Laurence JA, Araghi-Niknam M, Stary JM, Schulz SC, Lee S, Gottesman II.

Schizophr Res. 2004 Aug 1;69(2-3):317-23.

PMID:
15469203
17.

Two-dimensional assessment of cytoarchitecture in the superior temporal white matter in schizophrenia, major depressive disorder and bipolar disorder.

Beasley CL, Honavar M, Everall IP, Cotter D.

Schizophr Res. 2009 Dec;115(2-3):156-62. doi: 10.1016/j.schres.2009.09.028.

PMID:
19833481
19.

Evaluation of TrkB and BDNF transcripts in prefrontal cortex, hippocampus, and striatum from subjects with schizophrenia, bipolar disorder, and major depressive disorder.

Reinhart V, Bove SE, Volfson D, Lewis DA, Kleiman RJ, Lanz TA.

Neurobiol Dis. 2015 May;77:220-7. doi: 10.1016/j.nbd.2015.03.011. Epub 2015 Mar 18.

PMID:
25796564
20.

Investigation of m1/m4 muscarinic receptors in the anterior cingulate cortex in schizophrenia, bipolar disorder, and major depression disorder.

Zavitsanou K, Katsifis A, Mattner F, Huang XF.

Neuropsychopharmacology. 2004 Mar;29(3):619-25. Erratum in: Neuropsychopharmacology. 2005 Apr;31(4):896. Katerina, Zavitsanou [corrected to Zavitsanou, Katerina]; Andrew, Katsifis [corrected to Katsifis, Andrew]; Filomena, Mattner [corrected to Mattner, Filomena]; Xu-Feng, Huang [corrected to Huang, Xu-Feng].

Supplemental Content

Support Center